The Use of Urinary Dickkopf 3 (u DKK3) as a New Biomarker Which Can Identify Patients at High Risk of Renal Allograft Dysfunction, Earlier That the Current Established Tests.
Not yet recruitingOBSERVATIONAL
Enrollment
258
Participants
Timeline
Start Date
January 31, 2026
Primary Completion Date
July 31, 2026
Study Completion Date
January 31, 2027
Conditions
Renal Transplant Failure
Trial Locations (1)
SE1 7EH
Guy's and St Thomas' Hospital NHS foundation Trust, London
All Listed Sponsors
lead
Guy's and St Thomas' NHS Foundation Trust
OTHER
NCT07176806 - The Use of Urinary Dickkopf 3 (u DKK3) as a New Biomarker Which Can Identify Patients at High Risk of Renal Allograft Dysfunction, Earlier That the Current Established Tests. | Biotech Hunter | Biotech Hunter